ストックスクリーナーアプリを入手
2.52
3.08%
-0.08
Adagene Inc ADR (ADAG) 最新ニュース
Short Interest in Adagene Inc. (NASDAQ:ADAG) Expands By 6.3% - MarketBeat
MarketBeat
Short Interest in Adagene Inc. (NASDAQ:ADAG) Rises By 6.3% - Defense World
Defense World
WuXi AppTec Co. Ltd. Takes Position in Adagene Inc. (NASDAQ:ADAG) - MarketBeat
MarketBeat
WuXi AppTec Co. Ltd. Takes Position in Adagene Inc. (NASDAQ:ADAG) - MarketBeat
MarketBeat
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire Inc.
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewswire
GlobeNewswire
Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
GlobeNewswire Inc.
Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board - GlobeNewswire
GlobeNewswire
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024 - GlobeNewswire
GlobeNewswire
Adagene expands partnership with Merck for colorectal cancer - Clinical Trials Arena
Clinical Trials Arena
Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
GlobeNewswire Inc.
Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody ... - GlobeNewswire
GlobeNewswire
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 - ANTARA English
ANTARA English
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
Benzinga
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
GlobeNewswire Inc.
Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium
GlobeNewswire Inc.
Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody ... - Yahoo Finance
Yahoo Finance
Adagene to Present at Investor and Scientific Conferences in September - GlobeNewswire
GlobeNewswire
Adagene Achieves $3 Million Milestone in Collaboration with Exelixis for Successful Nomination of Second SAFEbody ... - Yahoo Finance
Yahoo Finance
Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo News UK
Yahoo News UK
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
InvestorPlace
Sanofi picks a 'safe' bet for Adagene's antibody tech in $2.5B biobucks tie up - Fierce Biotech
Fierce Biotech
Adagene Announces Strategic Collaboration Agreement with Tanabe Research Laboratories - PR Newswire
PR Newswire
0.79%
大文字化:
|
ボリューム (24 時間):